Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells
1 clinical trials · Condition
◉ Watch Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease (NCT04146038) | Rutgers, The State University of New Jersey | 2020-10-26 |
Track Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.